FA vs. OCTA? The status of OCTA, today. Fukuoka, JSOS 2016 Gerd Klose. Korobelnik J Fr Ophthalmol (2015)

Similar documents
Incorporating OCT Angiography Into Patient Care

ZEISS AngioPlex OCT Angiography Making the revolutionary, routine.

ZEISS AngioPlex OCT Angiography Overview ZEISS OCT Angiography

OCT Angiography The Next Frontier

10/17/2017. FDA Approved. Zeiss AngioPlex TM Optovue AngioVue TM

Visualize. Analyze. Personalize. OCT + OCTA

Will OCT-Angiography replace FA?

Swept-Source OCT Angiography: SS OCT Angio TM

Deeper visualizations for intervening with confidence.

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE RETINA AND OPTIC NERVE. Lindsay B. Howse, OD

Introducing ANGIOVUE ESSENTIAL. Built on the Avanti Widefield OCT Platform. OCT Angiography for Primary Eye Care

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

OCT Interpretation in Retinal Disease

OCT Angiography in Primary Eye Care

OCT Fundal Angiography Initial Experience The new era in Medical Retina Imaging Based on Cirrus 5000 AngioPlex 2016 Model Sheena George & Nicholas

OCT Angiography. Financial Disclosures: Pre-Test: Which one is Correct?

Leo Semes, OD, FAAO UAB Optometry

PLEX Elite 9000 from ZEISS Swept-Source OCT

OCT Angiography. SriniVas Sadda, MD

OCT Angiography: The Next Step in Retinal Imaging Jonathan Zelenak D.O.

ANSWERING THE WHY? Clinicians discuss the latest imaging technologies for retina practice BY PETER K. KAISER, MD

World Sight Day Case Studies. Mark Frost Screening Manager South East London DESP

The World s fastest OCT. As simple as pressing. the start button

Go With the Flow: An OCT Angiography Primer Lorne Yudcovitch, OD, MS, FAAO

Widefield Retinal Imaging with Auto Fluorescence Technology in the Optometric Practice

OCT-Angiography Clinical Cases. OCT-Angiography Clinical Cases

Visualize. Analyze. Personalize. OCT + OCTA. with

Experience Spectacular Retinal Imaging with the new NIDEK F-10 Digital Ophthalmoscope

Disclosures. Definitions. Goals. Imaging and glaucoma 3/22/2016

The Measure of Confidence

The role of OCT-A in retinal disease management

Technologies and Methods for Visualizing the Retina

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Optical Coherence Tomography Angiography In Diagnosis Of Retinal Angiomatous Proliferation

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

Clinical Study Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization

f.a.q s Q. Why should I have an iwellness exam?

Building The Retina Company

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES

Mark Dunbar: Disclosure

Photodynamic Therapy (PDT) for agerelated

Fluorescein Angiography

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014

Learn Connect Succeed. JCAHPO Regional Meetings 2017

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

The Human Eye. Cornea Iris. Pupil. Lens. Retina

APRIL 8th 2016 Therapy

Why Is Imaging Critical in My Uveitis Practice?

doi: /s

Amber Priority. Image Library

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May

Ultrahigh Speed Imaging of the Rat Retina Using Ultrahigh Resolution Spectral/Fourier Domain OCT

Rising to the Challenge of Satisfying Unmet Medical Needs. Back-of-the-eye. Main Back-of-the-Eye Diseases. Uveitis. Behcet s disease.

November Volume 35 - Issue 11

The retinal function imager and clinical applications

4/27/2010 INTRODUCTION TO RETINAL VASCULAR DISEASE VENOUS/VENULAR CENTRAL RETINAL VEIN OBSTRUCTION / CRVO ADDITIONAL FEATURES /COMPLICATIONS

LEE EYE CENTRE. YOUR VISION, OUR PASSION LEC EyeNews

A Patient s Guide to Diabetic Retinopathy

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care


Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?

The Era of anti- - - VEGF Kirk L. Halvorson, OD

*Pleasesee amendment forpennsylvaniamedicaid at the endofthis CPB.

OCT Angiography: An Upcoming Tool for Diagnosis and Treatment of Retinal Vascular Diseases

Case Report Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2 with Associated Subretinal Neovascular Membrane

DRI OCT Triton Series A Multimodal Swept Source OCT

Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015

Angio-OCT. Degenerazione Maculare Legata all Eta. Giuseppe Querques

Diabetic Retinopathy

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description

Chris Brown, M.D. Eye Specialty Group, PLC Continuing Education Series

Interesting, unusual and eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN

Interesting, unusual, eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN

! Honoraria. " Kemin " Nicox " Review of Optometry " Optometric Management " VSP. ! Scientific Advisory Boards

On Different Wavelengths: The Spectrum of Retinal Imaging. On Different Wavelengths: The Spectrum of Retinal Imaging. Wavelength Specific Imaging

Clinically Significant Macular Edema (CSME)

Common Causes of Vision Loss

Diabetic Retinopathy A Presentation for the Public

Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye

TOPCON EURETINA Clinical Advances and Applications With Swept Source OCT and Angiography. JANUARY/FEBRUARY 2019 VOL. 17, NO.

Clinical Study Optical Coherence Tomography and Optical Coherence Tomography Angiography in Monitoring Coats Disease

Adaptive Optics and OCTA: Update on Retinal Imaging. Judy E. Kim, MD Professor of Ophthalmology Medical College of Wisconsin

RVO RETINAL VEIN OCCLUSION

You can see clearly now. Heidelberg Retina Angiograph 2

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Case Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion

Polypoidal choroidal vasculopathy (PCV) is a variation of agerelated

RETINAL CONDITIONS RETINAL CONDITIONS

GENERAL INFORMATION DIABETIC EYE DISEASE

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan

Fundus autofluorescence in exudative age-related macular degeneration

NIH Public Access Author Manuscript Ophthalmology. Author manuscript; available in PMC 2015 January 01.

Comparison of Neovascular Lesion Area Measurements From Different Swept-Source OCT Angiographic Scan Patterns in Age-Related Macular Degeneration

Staphylomas in Pathologic Myopia With SS-OCT: A New Classification

FRANZCO, MD, MBBS. Royal Darwin Hospital

PRIMUS 200 from ZEISS The essential OCT

Diabetic Retinopatathy

Choroidal Mapping; a Novel Approach for Evaluating Choroidal Thickness and Volume

Transcription:

FA vs. OCTA? The status of OCTA, today Korobelnik J Fr Ophthalmol (2015) Fukuoka, JSOS 2016 Gerd Klose 1

2

FA / ICGA a well-founded Gold standard! Benefits Useful for many pathologies High contrast, detailed images Supports widefield imaging Choroidal imaging possible (w/ ICG) Well-established methodology 3

FA / ICGA with a flip-side Invasive & dye-based! Patient Discomfort Higher Clinical Effort 5% Adverse Effects: (nausea shock death) with many risk factors (age, diabetes, allergies, organ insuffiencies, pregnancy ) 4

FA / ICGA with a flip-side There is a constant balance between the clinical need and the risk of the diagnosis! What if you could reduce the number of FA exams 5

6

OCT Angiography sounds promising Presentations and Publications show so many nice images from OCT Angiography... providing fine structural details and 3D information non-invasive, quick and easy for patients & staff noncritical for sensitive patients, and allows frequent follow-ups 7

How does it work? Difference Bloodflow Average Structure 8

How does it work? Horizontal Vasculature Angio Cube Scans: 6x6 mm, 350 Ascans (17 um) 3x3 mm, 245 Ascans (12 um) Angio and Structure are complementary, you want to look at them side-by-side! 9

Quality Images require care at all levels Fast & Artifact-free Acquisition with Active tracking / Re-scan Reference Tracking (filtered) Amplitude & Phase Image Reconstruction Amplitude Phase Difference Zhang Q, et al., J. Biomed. Opt. 20(6), (2015) 10

Quality Images require care at all levels Post-Acquisition Multi-Step Motion Correction Correction of Projection Artifacts Corrected Deeper Retina 11

OCT-Angiography provides 3D information Choriocapillaris Slab Retina-Slab ILM to VRI- or Custom-Slab 70 um above RPE-fit Choroidor Custom-Slab Superficial Deeper Avascular 12

the Development will continue Quantification Larger Areas with Stitching ILM to Faster Swept-Source OCT-Angiography 70 um above RPE-fit 3x3 mm 6x6 mm 12 x12 mm Zhang Q, et al., J. Biomed. Opt. 20(6), (2015) / Dr. Philip J. Rosenfeld, BPEI / Dr. Y. Ito, Nagoya U 13

AngioPlex OCT Angiography simply another scan that works 14

15

FA / OCTA how about clinical usability FA detects the presence of dye/blood OCTA detects the flow of blood It is not identical, but similar and both can be utilized to visualize vasculature, (but not leakage or pooling) Pathologies resulting in neo-vascularization, low- or non-perfusion, and occlusions can be visualized! Korobelnik J Fr Ophthalmol (2015) 16

FA / OCTA how about clinical aspects many Clinical Cases have already been presented and many more to come: Diabetic Retinopathy (prolific / non-prolific) (DR) Central/Branch Retinal Vessel Occlusion (BRVO/CRVO) Age-related Macular Degeneration (AMD) Polypoidal Choroidal Vasculopathy (PCV) --------------------------------------------------------------------------- Macular Telangiectasia (Mactel) Coats like Exudative Maculopathy Sickle Cell Maculopathy Ocular tumors ---------------------------------------------------------------------------- Glaucoma 17

FA / OCTA DR + Micro-aneurysms + timely follow-up on photo-coagulation + novel combination treatment with anti-vegf + non-perfusion, ischemic areas + Visualization of Neo-vascularization - but often in periphery - limited sensitivity to aneurysms - limited cataract penetration no 100% FA replacement (yet) 18

FA / OCTA BRVO, CRVO, etc. + non-perfusion + detailed images of neo-vascularization + remodeling of vasculature + remodeling of vasculature + new treatment possibilities - limited in covered area & periphery - hemorrhages in acute phase - visibility of aneurysms, edema no 100% FA replacement (yet) 19

FA / OCTA Wet AMD & PCV + detailed visualization of CNV lesion + visualization of choroidal feeder trunk + GA acts as window to choroid + Treat and Extend follow-up with OCTA + Choroidal NV & polyps - limited in covered area - Treatment decision still triggered by Edema - Limited choroidal and small polyp visualization no 100% FA replacement (yet) 20

FA / OCTA Clinical benefits, today FA / ICGA is still needed! but in specific cases OCTA has already helped with differential diagnosis and improved treatment decisions and there are immediate, general benefits: non-invasive patient comfort & simplified clinical work 3D details potential improved treatment no dye risk reduction every FA replaced, helps enabling fast follow-up one last argument no doctor using OCTA wants to give it up afterwards! 21

22

OCTA the future is bright the benefits are now, and only keep growing 23